Walthausen & Co’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
SM
DCM
Walthausen & Co's ACLS Position: Q3 2022 in Review
Walthausen & Co reduced its Axcelis (ACLS) stake by 37% in Q3 2022, selling an estimated $898K and leaving 23,270 shares worth $1.41M. The position accounts for 1.18% of the portfolio, ranked #34.
Walthausen & Co first reported a position in ACLS in Q4 2020 and has held it in 8 quarters since. The position peaked at $2.8M in Q1 2021. 287 funds tracked by Wall St. Rank hold ACLS as of Q3 2022.
- Walthausen & Co held 23,270 shares of Axcelis worth $1.41M as of Q3 2022.
- Walthausen & Co sold 13,904 Axcelis shares in Q3 2022, an estimated $898K.
- Axcelis made up 1.18% of Walthausen & Co's portfolio in Q3 2022, its #34 holding.
- Walthausen & Co first reported a position in Axcelis in Q4 2020 and has held it in 8 quarters since.
- Walthausen & Co's Axcelis position peaked at $2.8M in Q1 2021.
- 287 funds tracked by Wall St. Rank held Axcelis as of Q3 2022.
Based on Walthausen & Co's 13F filing for Q3 2022, filed 14 Nov 2022.